News
BofA analyst Michael Ryskin raised the firm’s price target on Quest Diagnostics (DGX) to $198 from $190 and keeps a Buy rating on the shares.
In a report released today, Jason Goldberg from Barclays maintained a Buy rating on PNC Financial (PNC – Research Report), with a price target of $235.00. Discover outperforming stocks and ...
However, the firm asserts that without sustained LFL order growth and a solid track record of meeting earnings expectations, there seems to be no catalyst for a re-rating of the stock. Barclays ...
On Tuesday, Barclays (LON:BARC) downgraded Barry Callebaut AG (BARN:SW) (OTC: BYCBF) from Overweight to Equalweight, significantly reducing the price target to CHF900.00 from the previous CHF1,415.00.
However, the firm asserts that without sustained LFL order growth and a solid track record of meeting earnings expectations, there seems to be no catalyst for a re-rating of the stock. Barclays warns ...
There was a mix-up regarding my appointment for blood testing this morning. I arrived on time for my appointment but the kiosk indicated no appointment scheduled. It was 10 minutes to 12 (office ...
President Donald Trump's approval ratings are a measure of how Americans really feel about his job performance on any given day, often times driven by his handling of the issues at hand.
You can get in touch with Anna by emailing [email protected]. Trump has routinely touted positive approval ratings and polling during news conferences and campaign rallies throughout his ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results